Formulation of diltiazem affects cyclosporin-sparing activity

European Journal of Clinical Pharmacology

Volumn 52, Issue 1, 1997, Pages 55-58

  Jones, T E ^a   Morris, R G ^a   Mathew, T H ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

cyclosporinn A; diltiazem; drug metabolism; kidney transplantation; phrmacokinetics

Indexed keywords

CYCLOSPORIN A; DILTIAZEM;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG METABOLISM; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL;

ADULT; ANTIHYPERTENSIVE AGENTS; CHILD; CYCLOSPORINE; DELAYED-ACTION PREPARATIONS; DIFFUSION; DILTIAZEM; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 0030887735     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kronback T, Fischer V, Meyer UA (1988) Cyclosporine metabolism in human liver: identification of a P-450III gene family as the major cyclosporine-metabolising enzymes explains interactions with other drugs. Clin Pharmacol Ther 43: 630-635
2. Pichard L, Gillet G, Fahre I. Dalet-Beluche I, Bonfils C, Thenot J-P, Maurel P (1990) Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem. Drug Metab Dispos 18: 711-719
3. Patton PR, Brunson ME, Pfaff WW, Howard RJ, Peterson JC, Ramos EL, Karlix JL (1994) A preliminary report of diltiazem and ketoconazole. Transplantation 57: 889-892
4. Tortorice KL, Herm-Duthoy KL, Awani WM, Rao KV, Kasiske BL (1990) The effects of calcium channel blockers on cyclosporine and its metabolites in renal transplant recipients. Ther Drug Monit 12: 321-328
5. McLachlan A. Tett S (1995) Effect of metabolic inhibitors on cyclosporin A pharmacokinetics studied using a population approach. Ther Drug Monit 17: 400
6. Leibbrandt DM, Day RO (1992) Cyclosporin and calcium channel blockers: an exploitable drug interaction? Med J Aust 157: 296-297
7. Epstein M (1992) Calcium antagonists and renal protection. Current status and future perspectives. Arch Intern Med 152: 1573-1584
8. Morales JM, Rodriguez-Paternina E, Araque A, Hernandez E, Ruilpoe LM, Rodicio JL (1994) Long-term protective effect of a calcium antagonist on renal function in hypertensive renal transplant patients on cyclosporine therapy: A 5-year prospective randomized study. Transplant Proc 26: 2598-2599
9. Drewe J, Beglinger C, Kissel T (1992) The absorption site of cyclosporin in the human gastrointestinal tract. Br J Clin Pharmacol 33: 39-43
10. Krishna DR, Klotz U (1994) Extrahepatic metabolism of drugs in humans. Clin Pharmacokinet 26: 144-160
11. Kolars JC, Schmiedlin R. Schuetz JD, Fang C, Watkins PB (1992) Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J Clin Invest 90: 1871-1878
12. Hoppu K, Koskimies O, Holmberg C, Hirvisulo EL (1991) Evidence for pre-hepatic metabolism of oral cyclosporine in children. Br J Clin Pharmacol 32: 477-481
13. Tjia JF, Webber IR, Back DJ (1991) Cyclosporin metabolism by the gastrointestinal mucosa. Br J Clin Pharmacol 31: 344-346
14. Peters WH, Kremer PG (1989) Cytochromes P-450 in the intestinal mucosa of man. Biochem Pharmacol 38: 1535-1538
15. Pochet JM, Pirson Y (1986) Cyclosporin-diltiazem interaction. Lancet i: 979
16. Chrysostomou A, Walker RG, Russ GR, D'Apice AJF, Kincaid-Smith P, Mathew TH (1993) Diltiazem in renal allograft recipients receiving cyclosporine. Transplantation 55: 300-304
17. Brockmoller J, Neumayer H-H, Wagner K, Weber W, Heinimeyer G, Kewitz H, Roots I (1990) Pharmacokinetic interaction between cyclosporin and diltiazem. Eur J Clin Pharmacol 38: 237-242
18. Morris RG, Saccoia NC, Jones TE (1996) Modified liquid Chromatographic assay for diltiazem and metabolites in human plasma. J Liq Chromatogr Rel Technol 19: 2385-2394
19. Jones TE (1996) Survey of Cyclosporin-sparing agent use in Australasian transplant centres. Aust NZ J Med 26: 772-776
20. De Waziers I, Cugnenc PH, Yang CS, Leroux JP, Beaune PH (1990) Cytochrome P450 isoenzymes, epoxide hydroxylase and glutathione transferase in rat and human hepatic and extrahepatic tissues. J Pharmacol Exp Ther 253: 387-394
21. Watkins PB (1992) Drug metabolism by cytochromes P450 in the liver and small bowel. Gastrointest Pharmacol 21: 511 525
22. Gupta SK, Bakran A, Johnson RWG, Rowland M (1989) Cyclosporin erythromycin interaction in renal transplant patients. Br J Clin Pharmacol 27: 475-481